A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions

Alzheimer's DiseaseMild Cognitive Impairment

Interventions

DRUG

florbetapir (18F)

IV injection, 370 MBq(10mCi), single dose

Trial Locations (2)

Research Site, Kobe

Research Site, Tokyo